Analysts’ downgrades for Wednesday, August 16th:
OMV AG (OTCMKTS:OMVJF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “OMV Aktiengesellschaft (OMV AG) is an Austria-based integrated oil and gas company. It operates through two segments: Upstream and Downstream. The Upstream segment focuses on the exploration, development and production of oil and gas in three core regions: Central and Eastern Europe (CEE), the North Sea, as well as the Middle East and Africa. The Downstream segment comprises two business units: Downstream Oil, that operates around 3,800 filling stations in approximately 10 countries, refineries in Austria and Germany, both of which feature integrated petrochemical production, as well as the Petrobrazi refinery in Romania, which processes predominantly Romanian crude oil, and Downstream Gas, that focuses on gas trade and sales, as well as owns a pipeline network and gas storage facilities in Austria. “
Orion Corp (NASDAQ:ORINY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company’s core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland. “
Otter Tail Corporation (NASDAQ:OTTR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “OTTER TAIL’s primary business is the production, transmission, distribution and sale of electric energy. The Company, through its subsidiaries, is also engaged in other businesses which are referred to as Health Services Operations and Diversified Operations. “
OVID THERAPEUTC (NASDAQ:OVID) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company’s product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved in developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States. “
Oxford Lane Capital Corp (NASDAQ:OXLC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating.
Panasonic (NASDAQ:PCRFY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “PANASONIC CORPORATION is a worldwide leader in the development and manufacture of electronic products for a wide range of consumer, business, and industrial needs. The company’s shares are listed on the Tokyo, Osaka, Nagoya and New York stock exchanges. “
Park Hotels & Resorts (NYSE:PK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Park Hotels & Resorts Inc. is a lodging Real Estate Company. The company operates luxury hotels and resorts in USA and international market. Park Hotels & Resorts Inc. is based in Mc Lean, Virginia. “
Pioneer Power Solutions (NASDAQ:PPSI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Pioneer Power Solutions, Inc. is specialty manufacturer of electrical transmission and distribution equipment. The company provide solutions in the utility, industrial and commercial segments of the electrical transmission and distribution industry. It operates primarily in the U.S., Canada and Mexico. Pioneer Power Solutions, Inc. is headquartered in Fort Lee, New Jersey. “
POYDRAS GAMING FIN COM NPV (POST REV SPLIT) (NASDAQ:PYDGF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Poydras Gaming Finance Corp. is a regional slot route operator. The Company provides slot machines and related capital expenditures to existing casinos, new casino developments and gaming machine suppliers. Poydras Gaming Finance Corp. is based in Vancouver, Canada. “
Science Applications International Corporation (NYSE:SAIC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Science Applications International Corp. is engaged in transaction, technical, engineering and enterprise IT services business. The Company provides services in two segments: government segment and commercial segment. Its government segment servers primarily to United States federal, state and local government agencies and foreign governments. The commercial segment provides technology-driven consulting and systems integration services and solutions. Science Applications International Corp. is headquartered in McLean, VA. “
Superconductor Technologies (NASDAQ:SCON) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Superconductor Technologies Inc. manufactures and markets high-performance filters to service providers and original equipment manufacturers in the mobile wireless telecommunications industry. The company’s product, the SuperFilter, combines high-temperature superconductors with cryogenic cooling technology to produce a filter with significant advantages over conventional filters. The company was engaged primarily in research and development and generated revenues primarily from government research contracts. “
Selecta Biosciences (NASDAQ:SELB) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Selecta Biosciences, Inc. is a biopharmaceutical company which develops targeted immunotherapies and vaccines. Its product pipelineincludes gene therapy, food allergy, malaria; SEL-212, which is a therapeutic enzyme indicated for refractory gout; SEL-070, which is indicated for smoking cessation and relapse prevention; SEL-701, which is indicated for the treatment of human papillomavirus associated cancer and SEL-212 consists of SVP-Rapamycin co-administered with pegsiticase, its pegylated uricase. Selecta Biosciences, Inc. is based in Watertown, United States. “
